Research Needs in Philippine Pharmaceutical Sciences: A Qualitative Perspective from Regulatory and Clinical Research Sectors of the Pharmaceutical Industry
Imelda G. Peña, Honeymae C. Alos, Nicole Kaye R. Calara, Hilary Grace C. Pavia, Bryan Paul I. Bulatao · 2026
Read Research Needs in Philippine Pharmaceutical Sciences: A Qualitative Perspective from Regulatory and Clinical Research Sectors of the Pharmaceutical Industry by Imelda G. Peña, Honeymae C. Alos, Nicole Kaye R. Calara, Hilary Grace C. Pavia, Bryan Paul I. Bulatao (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13281454.txt.
Description
Imelda Peña and four co-authors asked industry leaders in two thousand twenty-six what drug research the Philippines most needs. They spoke with five senior figures from local and global drug firms, in the regulatory and clinical research arms. Open interviews and theme analysis shaped the picture across four areas, from drug discovery to regulatory science.
Thirteen shared themes emerged. They include half-finished development of healing compounds, shaky supply of raw materials, blurred rules for herbal products versus supplements, and weak government support for research. Gaps in skilled staff and slow approvals also featured. The authors say these overlooked needs can steer national research funds.
Catalog record
| CREATOR | Imelda G. Peña, Honeymae C. Alos, Nicole Kaye R. Calara, Hilary Grace C. Pavia, Bryan Paul I. Bulatao |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 93 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |